Histone marks interplay at LIFR enhancer determines the response to HDAC inhibitors in breast cancer
文献类型：期刊论文
| 作者 | Wang, Xiaomin; Xu, Jun; Ding, Jian ; Geng, Meiyu; Huang, Min
|
| 刊名 | CANCER RESEARCH
 |
| 出版日期 | 2019-07-01 |
| 卷号 | 79期号:13页码:2 |
| ISSN号 | 0008-5472 |
| DOI | 10.1158/1538-7445.AM2019-1407 |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:000488129903482 |
| 出版者 | AMER ASSOC CANCER RESEARCH |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/282646]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wang, Xiaomin,Xu, Jun,Ding, Jian,et al. Histone marks interplay at LIFR enhancer determines the response to HDAC inhibitors in breast cancer[J]. CANCER RESEARCH,2019,79(13):2. |
| APA | Wang, Xiaomin,Xu, Jun,Ding, Jian,Geng, Meiyu,&Huang, Min.(2019).Histone marks interplay at LIFR enhancer determines the response to HDAC inhibitors in breast cancer.CANCER RESEARCH,79(13),2. |
| MLA | Wang, Xiaomin,et al."Histone marks interplay at LIFR enhancer determines the response to HDAC inhibitors in breast cancer".CANCER RESEARCH 79.13(2019):2. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。